Theratechnologies Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Theratechnologies
THTX Stock  USD 1.20  0.01  0.83%   
Theratechnologies financial statements provide useful quarterly and yearly information to potential Theratechnologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Theratechnologies financial statements helps investors assess Theratechnologies' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Theratechnologies' valuation are summarized below:
Gross Profit
56.2 M
Profit Margin
(0.04)
Market Capitalization
55.2 M
Enterprise Value Revenue
0.8764
Revenue
84.3 M
We have found one hundred twenty available fundamental trend indicators for Theratechnologies, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Theratechnologies current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 35.7 M in 2024. Enterprise Value is likely to drop to about 56.9 M in 2024

Theratechnologies Total Revenue

98.73 Million

Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Total Revenue of 98.7 M or Gross Profit of 75 M, as well as many indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 62.42. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.
  
Check out the analysis of Theratechnologies Correlation against competitors.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Theratechnologies Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets65.2 M89.4 M67.7 M
Slightly volatile
Short and Long Term Debt Total37.4 M67.8 M36.1 M
Slightly volatile
Total Current Liabilities57.1 M54.4 M33 M
Slightly volatile
Property Plant And Equipment Net1.3 M1.8 M1.3 M
Slightly volatile
Accounts Payable6.4 M8 M7.5 M
Slightly volatile
Cash41.2 M39.2 M17.6 M
Slightly volatile
Non Current Assets Total29.9 M16.6 M21.6 M
Slightly volatile
Cash And Short Term Investments49.3 M47 M24.6 M
Slightly volatile
Net Receivables15.5 M14.7 M8.2 M
Slightly volatile
Common Stock Shares Outstanding23.5 M23.7 M19.3 M
Slightly volatile
Non Current Liabilities Total62 M59 M28.9 M
Slightly volatile
Inventory7.8 M7 M12.5 M
Pretty Stable
Other Current Assets4.9 M4.7 M3.7 M
Slightly volatile
Total Liabilities119.1 M113.4 M59.1 M
Slightly volatile
Total Current Assets76.4 M72.8 M48.8 M
Slightly volatile
Short Term Debt9.2 M8.9 M9 M
Slightly volatile
Intangible Assets13.2 M14.4 M16 M
Slightly volatile
Other Current Liabilities39.4 M37.5 M17.3 M
Slightly volatile
Short Term Investments9.6 M6.1 M8 M
Slightly volatile
Property Plant And Equipment Gross1.5 M2.9 M1.7 M
Slightly volatile
Common Stock Total Equity282.6 M330.4 M269.6 M
Slightly volatile
Common Stock306.7 M418.5 M290 M
Slightly volatile
Other Liabilities90.6 K95.4 K6.1 M
Slightly volatile
Long Term Debt38.2 M58.3 M30.8 M
Slightly volatile
Long Term Debt Total66.8 M63.6 M34.2 M
Slightly volatile
Capital Surpluse10.5 M12.4 M9.3 M
Slightly volatile
Property Plant Equipment3.7 M3.6 M1.4 M
Slightly volatile
Non Current Liabilities Other35.1 K36.9 K3.5 M
Slightly volatile
Net Invested Capital45.8 M33.4 M45.4 M
Slightly volatile
Short and Long Term Debt8 M8.4 M25.4 M
Slightly volatile
Capital Stock342 M418.5 M292.9 M
Slightly volatile
Capital Lease Obligations1.7 M894.6 K2.5 M
Slightly volatile
Deferred Long Term Liabilities1.3 M2.1 M920.2 K
Slightly volatile

Theratechnologies Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.1 M3.8 M3.8 M
Slightly volatile
Total Revenue98.7 M94 M47.2 M
Slightly volatile
Other Operating Expenses111.6 M106.2 M51.8 M
Slightly volatile
Research Development36.7 M34.9 M16.3 M
Slightly volatile
Cost Of Revenue23.7 M22.6 M16.4 M
Slightly volatile
Selling General Administrative9.3 M18 M9.1 M
Slightly volatile
Selling And Marketing Expenses16.5 M30.8 M17.8 M
Slightly volatile
Interest Income457.6 K692.1 K829.5 K
Slightly volatile
Reconciled Depreciation7.3 M3.8 M4.4 M
Slightly volatile

Theratechnologies Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow28.8 M27.4 M13.6 M
Slightly volatile
Depreciation3.1 M3.8 M3.9 M
Slightly volatile
End Period Cash Flow41.2 M39.2 M17.5 M
Slightly volatile
Stock Based Compensation2.7 M2.5 M1.3 M
Slightly volatile
Change To Netincome6 M8.1 M5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.560.5959.4486
Slightly volatile
Days Sales Outstanding62.4265.7273
Slightly volatile
Average Payables3.5 M2.3 M2.1 M
Slightly volatile
Stock Based Compensation To Revenue0.02730.03120.0227
Slightly volatile
Capex To Depreciation0.880.630.5195
Slightly volatile
EV To Sales0.890.9458.5382
Slightly volatile
Inventory Turnover3.062.911.1875
Slightly volatile
Days Of Inventory On Hand107101893
Slightly volatile
Payables Turnover2.652.532.1924
Very volatile
Sales General And Administrative To Revenue0.340.220.2843
Slightly volatile
Average Inventory15.1 M14.4 M12 M
Slightly volatile
Research And Ddevelopement To Revenue0.410.430.8536
Slightly volatile
Capex To Revenue0.02430.02560.059
Slightly volatile
Cash Per Share1.871.780.5697
Slightly volatile
Intangibles To Total Assets0.140.16070.206
Very volatile
Current Ratio1.461.541.9986
Slightly volatile
Receivables Turnover5.695.756.1796
Very volatile
Graham Number2.434.631.544
Slightly volatile
Capex Per Share0.08340.07940.0243
Slightly volatile
Average Receivables4 M3.8 M3.4 M
Slightly volatile
Revenue Per Share2.932.790.9584
Slightly volatile
Interest Debt Per Share2.462.340.7448
Slightly volatile
Debt To Assets0.70.670.4357
Slightly volatile
Operating Cycle1611531.2 K
Slightly volatile
Ebt Per Ebit2.091.991.2917
Slightly volatile
Long Term Debt To Capitalization1.611.530.8729
Slightly volatile
Total Debt To Capitalization1.481.410.7598
Slightly volatile
Quick Ratio1.321.391.2847
Pretty Stable
Net Income Per E B T1.091.170.9567
Slightly volatile
Cash Ratio1.190.830.6565
Very volatile
Days Of Inventory Outstanding107101893
Slightly volatile
Days Of Sales Outstanding62.4265.7273
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.861.191.0447
Pretty Stable
Fixed Asset Turnover35.3837.24169
Pretty Stable
Debt Ratio0.70.670.4357
Slightly volatile
Price Sales Ratio0.560.5959.4486
Slightly volatile
Asset Turnover0.990.950.5865
Slightly volatile
Gross Profit Margin0.960.870.7088
Slightly volatile

Theratechnologies Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap35.7 M37.6 M575 M
Very volatile
Enterprise Value56.9 M59.9 M588.4 M
Pretty Stable

Theratechnologies Fundamental Market Drivers

Forward Price Earnings17.1821
Cash And Short Term Investments40.9 M

Theratechnologies Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
10th of April 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
30th of November 2022
Last Financial Announcement
View

About Theratechnologies Financial Statements

Theratechnologies investors use historical fundamental indicators, such as Theratechnologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theratechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue34.2 K32.5 K
Total Revenue94 M98.7 M
Cost Of Revenue22.6 M23.7 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.22  0.34 
Research And Ddevelopement To Revenue 0.43  0.41 
Capex To Revenue 0.03  0.02 
Revenue Per Share 2.79  2.93 
Ebit Per Revenue(0.13)(0.12)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY